Chinese cell therapy effective in small multiple myeloma trial – Reuters
|
Chinese cell therapy effective in small multiple myeloma trial
Reuters The study of 35 patients tested a chimeric antigen receptor T–cell (CAR-T) therapy developed by China's Nanjing Legend Biotech Co. The drug candidate, known as LCAR-B38M, targets a protein called BCMA found on cancerous blood plasma cells – the … |
